Phillippe Bachellier

Summary

Country: France

Publications

  1. doi request reprint Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension
    Philippe Bachellier
    Hepato Pancreato Biliary Surgery and Liver Transplantation, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre Hôpitaux Universitaires de Strasbourg, Universite de Strasbourg, Strasbourg, France Electronic address
    Surgery 155:449-56. 2014
  2. doi request reprint Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study
    Philippe Bachellier
    Centre de Chirurgie Viscerale et de Transplantation, Hopitaux Universitaires de Strasbourg, CHU Hautepierre, Strasbourg Cedex, France
    J Surg Oncol 103:75-84. 2011
  3. pmc Laparoscopic treatment of biliary peritonitis following nonoperative management of blunt liver trauma
    Ettore Marzano
    Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre Universitaires de Strasbourg, Avenue Moliere, 67098 Strasbourg Cedex, France
    World J Emerg Surg 5:26. 2010
  4. pmc Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
    Stefan Heinrich
    Department of General and Abdominal Surgery, University Hospital of Mainz, Langenbeck Strasse 1, 55118 Mainz, Germany
    BMC Cancer 11:346. 2011

Collaborators

  • Daniel Jaeck
  • Stefan Heinrich
  • Ettore Marzano
  • Bernhard Pestalozzi
  • Pierre Alain Clavien
  • Achim Weber
  • Hauke Lang
  • Frederik Berrevoet
  • Xavier Rogiers
  • Markus Moehler
  • Jean Luc Raoul
  • Mickael Lesurtel
  • Stephanie Laurent
  • Patrick Dufour
  • Jean Robert Delpero
  • Elie Oussoultzoglou
  • Patrick Pessaux
  • Edoardo Rosso
  • Olivier Collange

Detail Information

Publications4

  1. doi request reprint Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension
    Philippe Bachellier
    Hepato Pancreato Biliary Surgery and Liver Transplantation, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre Hôpitaux Universitaires de Strasbourg, Universite de Strasbourg, Strasbourg, France Electronic address
    Surgery 155:449-56. 2014
    ....
  2. doi request reprint Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study
    Philippe Bachellier
    Centre de Chirurgie Viscerale et de Transplantation, Hopitaux Universitaires de Strasbourg, CHU Hautepierre, Strasbourg Cedex, France
    J Surg Oncol 103:75-84. 2011
    ..Arterial resection (AR) has traditionally been considered as a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma. The objective was to evaluate if pancreatic resection with AR was worthwhile...
  3. pmc Laparoscopic treatment of biliary peritonitis following nonoperative management of blunt liver trauma
    Ettore Marzano
    Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre Universitaires de Strasbourg, Avenue Moliere, 67098 Strasbourg Cedex, France
    World J Emerg Surg 5:26. 2010
    ..However, it is associated with several in-hospital complications. In selected cases laparoscopy could be proposed as diagnostic and therapeutic means...
  4. pmc Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
    Stefan Heinrich
    Department of General and Abdominal Surgery, University Hospital of Mainz, Langenbeck Strasse 1, 55118 Mainz, Germany
    BMC Cancer 11:346. 2011
    ..Moreover, neoadjuvant chemotherapy improves the nutritional status of patients with pancreatic cancer. This multicenter phase III trial (NEOPAC) has been designed to explore the efficacy of neoadjuvant chemotherapy...